448 related articles for article (PubMed ID: 29458383)
1. Cumulative exposure to environmental pollutants during early pregnancy and reduced fetal growth: the Project Viva cohort.
Rokoff LB; Rifas-Shiman SL; Coull BA; Cardenas A; Calafat AM; Ye X; Gryparis A; Schwartz J; Sagiv SK; Gold DR; Oken E; Fleisch AF
Environ Health; 2018 Feb; 17(1):19. PubMed ID: 29458383
[TBL] [Abstract][Full Text] [Related]
2. Early-Pregnancy Plasma Concentrations of Perfluoroalkyl Substances and Birth Outcomes in Project Viva: Confounded by Pregnancy Hemodynamics?
Sagiv SK; Rifas-Shiman SL; Fleisch AF; Webster TF; Calafat AM; Ye X; Gillman MW; Oken E
Am J Epidemiol; 2018 Apr; 187(4):793-802. PubMed ID: 29155920
[TBL] [Abstract][Full Text] [Related]
3. Prenatal exposure to perfluoroalkyl substances and birth outcomes in a Spanish birth cohort.
Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Iñiguez C; Martinez D; Costa O; Santa-Marina L; Pereda-Pereda E; Schettgen T; Sunyer J; Vrijheid M
Environ Int; 2017 Nov; 108():278-284. PubMed ID: 28917208
[TBL] [Abstract][Full Text] [Related]
4. Prenatal exposure to 11 perfluoroalkyl substances and fetal growth: A large-scale, prospective birth cohort study.
Kashino I; Sasaki S; Okada E; Matsuura H; Goudarzi H; Miyashita C; Okada E; Ito YM; Araki A; Kishi R
Environ Int; 2020 Mar; 136():105355. PubMed ID: 32029284
[TBL] [Abstract][Full Text] [Related]
5. Maternal Plasma per- and Polyfluoroalkyl Substance Concentrations in Early Pregnancy and Maternal and Neonatal Thyroid Function in a Prospective Birth Cohort: Project Viva (USA).
Preston EV; Webster TF; Oken E; Claus Henn B; McClean MD; Rifas-Shiman SL; Pearce EN; Braverman LE; Calafat AM; Ye X; Sagiv SK
Environ Health Perspect; 2018 Feb; 126(2):027013. PubMed ID: 29488882
[TBL] [Abstract][Full Text] [Related]
6. Association of Early Pregnancy Perfluoroalkyl and Polyfluoroalkyl Substance Exposure With Birth Outcomes.
Zhang Y; Mustieles V; Sun Q; Coull B; McElrath T; Rifas-Shiman SL; Martin L; Sun Y; Wang YX; Oken E; Cardenas A; Messerlian C
JAMA Netw Open; 2023 May; 6(5):e2314934. PubMed ID: 37256622
[TBL] [Abstract][Full Text] [Related]
7. Maternal plasma concentrations of perfluoroalkyl and polyfluoroalkyl substances during pregnancy and anogenital distance in male infants.
Tian Y; Liang H; Miao M; Yang F; Ji H; Cao W; Liu X; Zhang X; Chen A; Xiao H; Hu H; Yuan W
Hum Reprod; 2019 Jul; 34(7):1356-1368. PubMed ID: 31242507
[TBL] [Abstract][Full Text] [Related]
8. Prenatal exposure to perfluoroalkyl substances, immune-related outcomes, and lung function in children from a Spanish birth cohort study.
Manzano-Salgado CB; Granum B; Lopez-Espinosa MJ; Ballester F; Iñiguez C; Gascón M; Martínez D; Guxens M; Basterretxea M; Zabaleta C; Schettgen T; Sunyer J; Vrijheid M; Casas M
Int J Hyg Environ Health; 2019 Jul; 222(6):945-954. PubMed ID: 31262703
[TBL] [Abstract][Full Text] [Related]
9. Maternal serum levels of perfluoroalkyl substances in early pregnancy and offspring birth weight.
Wikström S; Lin PI; Lindh CH; Shu H; Bornehag CG
Pediatr Res; 2020 May; 87(6):1093-1099. PubMed ID: 31835271
[TBL] [Abstract][Full Text] [Related]
10. Effect of perfluoroalkyl exposure in pregnancy and infancy on intrauterine and childhood growth and anthropometry. Sub study from COPSAC2010 birth cohort.
Sevelsted A; Gürdeniz G; Rago D; Pedersen CT; Lasky-Su JA; Checa A; Zhang P; Wheelock CE; Normann SS; Kristensen DM; Rasmussen MA; Schullehner J; Sdougkou K; Martin JW; Stokholm J; Bønnelykke K; Bisgaard H; Chawes B
EBioMedicine; 2022 Sep; 83():104236. PubMed ID: 36030647
[TBL] [Abstract][Full Text] [Related]
11. Maternal exposure to perfluorinated acids and fetal growth.
Hamm MP; Cherry NM; Chan E; Martin JW; Burstyn I
J Expo Sci Environ Epidemiol; 2010 Nov; 20(7):589-97. PubMed ID: 19865074
[TBL] [Abstract][Full Text] [Related]
12. Transfer of perfluoroalkyl substances from mother to fetus in a Spanish birth cohort.
Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Basterrechea M; Grimalt JO; Jiménez AM; Kraus T; Schettgen T; Sunyer J; Vrijheid M
Environ Res; 2015 Oct; 142():471-8. PubMed ID: 26257032
[TBL] [Abstract][Full Text] [Related]
13. Perfluoroalkyl and polyfluoroalkyl substances and human fetal growth: a systematic review.
Bach CC; Bech BH; Brix N; Nohr EA; Bonde JP; Henriksen TB
Crit Rev Toxicol; 2015 Jan; 45(1):53-67. PubMed ID: 25372700
[TBL] [Abstract][Full Text] [Related]
14. Prenatal exposure to per- and polyfluoroalkyl substances and infant growth and adiposity: the Healthy Start Study.
Starling AP; Adgate JL; Hamman RF; Kechris K; Calafat AM; Dabelea D
Environ Int; 2019 Oct; 131():104983. PubMed ID: 31284113
[TBL] [Abstract][Full Text] [Related]
15. Prenatal plasma concentrations of Perfluoroalkyl and polyfluoroalkyl substances and neuropsychological development in children at four years of age.
Niu J; Liang H; Tian Y; Yuan W; Xiao H; Hu H; Sun X; Song X; Wen S; Yang L; Ren Y; Miao M
Environ Health; 2019 Jun; 18(1):53. PubMed ID: 31196101
[TBL] [Abstract][Full Text] [Related]
16. Associations of Exposure to Perfluoroalkyl Substances With Thyroid Hormone Concentrations and Birth Size.
Xiao C; Grandjean P; Valvi D; Nielsen F; Jensen TK; Weihe P; Oulhote Y
J Clin Endocrinol Metab; 2020 Mar; 105(3):735-45. PubMed ID: 31665456
[TBL] [Abstract][Full Text] [Related]
17. Prenatal exposure to per- and polyfluoroalkyl substances and maternal and neonatal thyroid function in the Project Viva Cohort: A mixtures approach.
Preston EV; Webster TF; Claus Henn B; McClean MD; Gennings C; Oken E; Rifas-Shiman SL; Pearce EN; Calafat AM; Fleisch AF; Sagiv SK
Environ Int; 2020 Jun; 139():105728. PubMed ID: 32311629
[TBL] [Abstract][Full Text] [Related]
18. Exposure to Perfluoroalkyl Substances and Metabolic Outcomes in Pregnant Women: Evidence from the Spanish INMA Birth Cohorts.
Matilla-Santander N; Valvi D; Lopez-Espinosa MJ; Manzano-Salgado CB; Ballester F; Ibarluzea J; Santa-Marina L; Schettgen T; Guxens M; Sunyer J; Vrijheid M
Environ Health Perspect; 2017 Nov; 125(11):117004. PubMed ID: 29135438
[TBL] [Abstract][Full Text] [Related]
19. Associations of Maternal Stress, Prenatal Exposure to Per- and Polyfluoroalkyl Substances (PFAS), and Demographic Risk Factors with Birth Outcomes and Offspring Neurodevelopment: An Overview of the ECHO.CA.IL Prospective Birth Cohorts.
Eick SM; Enright EA; Geiger SD; Dzwilewski KLC; DeMicco E; Smith S; Park JS; Aguiar A; Woodruff TJ; Morello-Frosch R; Schantz SL
Int J Environ Res Public Health; 2021 Jan; 18(2):. PubMed ID: 33467168
[TBL] [Abstract][Full Text] [Related]
20. Prenatal Exposure to Perfluoroalkyl Substances and Cardiometabolic Risk in Children from the Spanish INMA Birth Cohort Study.
Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Iñiguez C; Martinez D; Romaguera D; Fernández-Barrés S; Santa-Marina L; Basterretxea M; Schettgen T; Valvi D; Vioque J; Sunyer J; Vrijheid M
Environ Health Perspect; 2017 Sep; 125(9):097018. PubMed ID: 28934720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
